Literature DB >> 16195700

Induction of stable RNA interference in mammalian cells.

Bryan R Cullen1.   

Abstract

Over the last years, RNA interference (RNAi) has become a widely used technique that permits the knock-down, and hence functional analysis, of individual genes in vertebrate cells. However, the high failure rate of the RNA molecules used in RNAi experiments continues to be a problem. In this paper, I describe a set of design criteria, experimental steps and expression vectors that can facilitate the effective knock-down of almost any vertebrate gene product in cultured cells or in experimental animals.Gene Therapy (2006) 13, 503-508. doi:10.1038/sj.gt.3302656; published online 29 September 2005.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16195700     DOI: 10.1038/sj.gt.3302656

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  25 in total

Review 1.  A primer on using pooled shRNA libraries for functional genomic screens.

Authors:  Guang Hu; Ji Luo
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2012-02       Impact factor: 3.848

Review 2.  Lentiviral vector-mediated RNA silencing in the central nervous system.

Authors:  Thomas H Hutson; Edmund Foster; Lawrence D F Moon; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther Methods       Date:  2013-11-01       Impact factor: 2.396

3.  Optimization of a Genome-Wide Disordered Lentivector-Based Short Hairpin RNA Library.

Authors:  O A Guryanova; M Makhanov; A A Chenchik; P M Chumakov; E I Frolova
Journal:  Mol Biol       Date:  2006-05-01       Impact factor: 1.374

Review 4.  RNA interference and its role in cancer therapy.

Authors:  Behzad Mansoori; Siamak Sandoghchian Shotorbani; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2014-08-10

5.  A computational algorithm to predict shRNA potency.

Authors:  Simon R V Knott; Ashley Maceli; Nicolas Erard; Kenneth Chang; Krista Marran; Xin Zhou; Assaf Gordon; Osama El Demerdash; Elvin Wagenblast; Sun Kim; Christof Fellmann; Gregory J Hannon
Journal:  Mol Cell       Date:  2014-11-26       Impact factor: 17.970

Review 6.  RNAi: a potential new class of therapeutic for human genetic disease.

Authors:  Attila A Seyhan
Journal:  Hum Genet       Date:  2011-05-03       Impact factor: 4.132

7.  Optimization of duplex stability and terminal asymmetry for shRNA design.

Authors:  Olga V Matveeva; Yibin Kang; Alexey N Spiridonov; Pål Saetrom; Vladimir A Nemtsov; Aleksey Y Ogurtsov; Yury D Nechipurenko; Svetlana A Shabalina
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

8.  Logic integration of mRNA signals by an RNAi-based molecular computer.

Authors:  Zhen Xie; Siyuan John Liu; Leonidas Bleris; Yaakov Benenson
Journal:  Nucleic Acids Res       Date:  2010-03-01       Impact factor: 16.971

9.  Silencing the NR2B gene in rat ACC neurons by lentivirus-delivered shRNA alleviates pain-related aversion.

Authors:  Shou-Gang Guo; Xiu-Hua Lv; Shan-Hui Guan; Hui-Lu Li; Yong Qiao; Hao Feng; Lin Cong; Gong-Ming Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

10.  Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer.

Authors:  Zhenfeng Duan; Edward J Weinstein; Diana Ji; Rachel Y Ames; Edwin Choy; Henry Mankin; Francis J Hornicek
Journal:  Mol Cancer Ther       Date:  2008-08-07       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.